အေမရိကန္ ႏိုင္ငံကို ေရာက္ရွိေနသည့္ အီလိုလာပိုး ကူးဆက္ခံေနရသူေဒါက္တာ ဘရက္ဒလီ ကို
ZMapp ဟုေခၚသည့္ ေဆးရြက္ႀကီး ပင္တမ်ိဳးက ေဖၚစပ္ထားတဲ့ေဆးနဲ႔ ကုသလိုက္တဲ့အခါ. အီဘိုလာ ကူးစက္ခံလာရတဲ့ ေဒါက္တာ ဘရက္ဒလီ တေယာက္ခ်က္ခ်င္းသက္သာလာတယ္ ဆိုပါတယ္။ အေမရိက က အတ္လန္တာ ေဆး႐ုံ မွာ ကုသ ေနပါတယ္ ။ေရာဂါရွိတဲ့ေမ်ာက္ေတြကို စမ္းသတ္ကုသတဲ့အခါ သုံးပုံ. ႏွစ္ပုံ. အသက္. ရွင္တယ္ ဆိုပါတယ္။
ယခုေဆးရြတ္ၾကီးပင္မ်ိဳးမွာ ျသစေတးလ်Australia ႏိုင္ငံမွာေပါက္ေရာက္ျပီး ေဆးျပင္းလိတ္ထုတ္လုပ္တဲ့ အပင္မ်ိဳးမွာပါ၀င္ျပီး ေမ်ာက္ေတြကို အရင္စမ္းသတ္ခဲ့တာ တိုးတက္မွဳေတြေတြ ့ရျပီး ပိုးေတြအား ေလ်ွာ့ကုန္ေၾကာင္း။
ဌင္းေဆးအာနိသင္မွာ အဆိပ္ေတာက္မ်ားကို ႏိုင္သည္-ပိုးမ်ားကိုေသေစႏိုင္ပါသည္ ။ ဌင္းေဆး အား လြန္ခဲ့ေသာ ၁၀ႏွစ္ခန္ ့ကပင္ စမ္းသတ္မွုမ်ားျပဳလုပ္ေနခဲ့သည္။
ယခုအီဘိုလာ လူနာ ေဒါက္တာ ဘရက္လီ ျပန္လည္ေနေကာင္းေအာင္ ကုသျပီးပါက အာဖရိက ႏိုင္ငံမ်ားမွ အေသေစာင့္ေရၾကသည့္ လူနာမ်ားအတြက္ ၀မ္းေျမာက္ဖြယ္ျဖစ္သည္။
ေကာင္းက်ိဳးမေပး မူးရစ္ေဆးဆိုေသာ္လည္း လူသားေတြအသက္ကယ္တင္ႏိုင္သည့္ ေဆးရြတ္ၾကီး မ်ိဳးပင္မွာ အီဘိုလာႏိုင္သည့္ ကယ္တင္ရွင္အပင္ျဖစ္လာႏိုင္သည္။
Ref:http://www.themeltingpot4u.com/2014/08/blog-post_23.html?m=1
ဆက္စပ္သတင္း.......
Ebola virus disease
http://en.wikipedia.org/wiki/Ebola_virus_disease
CDC director: More study needed of Ebola medicine made in Kentucky
bestep@herald-leader.comAugust 5, 2014
Tobacco plants growing in greenhouses in Owensboro are being used to make the experimental serum to fight Ebola. PHOTO PROVIDED
Even if two victims of the deadly Ebola virusrecover after being given a medicine derived from genetically modified tobacco, much more study would be needed to confirm whether the drug worked, the head of the Centers for Disease Control and Prevention said Tuesday.
It would be wonderful if the serum grown from tobacco works, but two patients is far too small a sample to make conclusions about the medicine produced in Owensboro, Dr. Thomas Frieden said Tuesday during an appearance in Hazard.
"You can't conclude anything from how two patients do, other than it's wonderful if they get better," Frieden said.
The serum was produced at Kentucky BioProcessing, which conducts research and development for San Diego-based Mapp Biopharmaceutical, according to a company spokesman.
Two Americans infected with Ebola have been given the drug, called ZMapp, and have shown improvement.
The drug apparently had not been tested on humans, but a federal study published last year showed that 43 percent of infected primates given the drug recovered.
If the two people being given the drug recover, rigorous study of the medicine would be needed "so we'll know, definitively and scientifically, does it help, does it hurt or does it not make any difference at all?" Frieden said.
That's not clear now, he said, noting that there is no proven treatment or vaccine for the disease.
Frieden said the current Ebola outbreak in West Africa, which has killed more than 600 people, is the worst the world has ever seen.
The CDC will send 50 more staffers to the affected countries within 15 days to help contain the outbreak, Frieden said.
Ebola is spread through contact with the bodily fluids of infected people. Limiting that contact in health-care centers, and changing burial practices in the affected region to limit such contact, will help stem the outbreak, Frieden said.
Frieden said Ebola is not spread as easily as some other infections, such as the common cold, but it's scary because the death rate is high once people contract the disease.
The CDC has said there is little risk of an Ebola outbreak in the United States.
Frieden said authorities and health workers have been able to stop every prior Ebola outbreak, and that he is confident the current outbreak will be contained if the proper measures are used.
But right now, "the problem is still very much not in control," he said.
The two Americans infected are health-care workers who had been in Afric
Credit @ Ko Nge
No comments:
Post a Comment